Metabolic syndrome is an aggregation of conditions and associated with an increased risk of develop-ing diabetes, obesity and cardiovascular diseases (CVD). Edible mushrooms are widely consumed in many coun-tries and are valuable components of the diet because of their attractive taste, aroma, and nutritional value. Medicinal mushrooms are higher fungi with additional nutraceutical attributes having low-fat content and a trans-isomer of unsaturated fatty acids along with high fiber content, biologically active compounds such as polysaccharides or polysaccharide β-glucans, alkaloids, steroids, polyphenols and terpenoids. In vitro experiments, ani-mal models, and even human studies have demonstrated not only fresh edible mushroom but also mushroom extract that has great therapeutic applications in human health as they possess many properties such as anti-obesity, cardioprotective and anti-diabetic effect. They are considered as the unmatched source of healthy foods and drugs. The focus of this report was to provide a concise and complete review of the novel medicinal properties of fresh or dry mushroom and extracts, fruiting body or mycelium and its extracts, fiber, polysaccharides, beta-glucan, triterpenes, fucoidan, ergothioneine from edible mushrooms that may help to prevent or treat metabolic syndrome and associated diseases.

Original languageEnglish
Pages (from-to)4970-4981
Number of pages12
JournalCurrent Pharmaceutical Design
Issue number39
Publication statusPublished - 2020


  • Anti-diabetic activity
  • Anti-obesity activity
  • Cardioprotective activities
  • Edible mushroom
  • Metabolic disorders
  • Novel medicinal properties
  • Polysaccharide

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Edible mushrooms: Novel medicinal agents to combat metabolic syndrome and associated diseases'. Together they form a unique fingerprint.

Cite this